Bhargava R - Search Results

1

Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy.

Horne ZD, Dohopolski MJ, Pradhan D, Bhargava R, Edwards RP, Kelley JL, Comerci JT, Olawaiye AB, Courtney-Brooks MB, Bockmeier MM, Berger JL, Taylor SE, Sukumvanich P, Beriwal S. Horne ZD, et al. Among authors: bhargava r. Gynecol Oncol. 2018 Oct;151(1):96-101. doi: 10.1016/j.ygyno.2018.08.002. Epub 2018 Aug 3. Gynecol Oncol. 2018. PMID: 30082072

2

Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.

Bhargava R, Beriwal S, Dabbs DJ. Bhargava R, et al. Am J Clin Pathol. 2007 Jan;127(1):103-13. doi: 10.1309/TDP92PQLDE2HLEET. Am J Clin Pathol. 2007. PMID: 17145637

3

Mucosa-associated lymphoid tissue lymphoma of the cervix.

Coon D, Beriwal S, Swerdlow SH, Bhargava R. Coon D, et al. Among authors: bhargava r. J Clin Oncol. 2008 Jan 20;26(3):503-4. doi: 10.1200/JCO.2007.14.3784. J Clin Oncol. 2008. PMID: 18202426 No abstract available.

4

Histopathologic variables predict Oncotype DX recurrence score.

Flanagan MB, Dabbs DJ, Brufsky AM, Beriwal S, Bhargava R. Flanagan MB, et al. Among authors: bhargava r. Mod Pathol. 2008 Oct;21(10):1255-61. doi: 10.1038/modpathol.2008.54. Mod Pathol. 2008. PMID: 18360352 Free article.

5

WT1 immunoreactivity in breast carcinoma: selective expression in pure and mixed mucinous subtypes.

Domfeh AB, Carley AL, Striebel JM, Karabakhtsian RG, Florea AV, McManus K, Beriwal S, Bhargava R. Domfeh AB, et al. Among authors: bhargava r. Mod Pathol. 2008 Oct;21(10):1217-23. doi: 10.1038/modpathol.2008.69. Epub 2008 May 9. Mod Pathol. 2008. PMID: 18469795 Free article.

6

CK5 is more sensitive than CK5/6 in identifying the "basal-like" phenotype of breast carcinoma.

Bhargava R, Beriwal S, McManus K, Dabbs DJ. Bhargava R, et al. Am J Clin Pathol. 2008 Nov;130(5):724-30. doi: 10.1309/AJCP3KFF1LTYWQIY. Am J Clin Pathol. 2008. PMID: 18854264

7

Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers.

Bhargava R, Striebel J, Beriwal S, Flickinger JC, Onisko A, Ahrendt G, Dabbs DJ. Bhargava R, et al. Int J Clin Exp Pathol. 2009;2(5):444-55. Epub 2009 Feb 9. Int J Clin Exp Pathol. 2009. PMID: 19294003 Free PMC article.

8

Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.

Bhargava R, Beriwal S, Striebel JM, Dabbs DJ. Bhargava R, et al. Appl Immunohistochem Mol Morphol. 2010 Mar;18(2):113-8. doi: 10.1097/PAI.0b013e3181b94ff1. Appl Immunohistochem Mol Morphol. 2010. PMID: 19801938

9

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.

Niemeier LA, Dabbs DJ, Beriwal S, Striebel JM, Bhargava R. Niemeier LA, et al. Among authors: bhargava r. Mod Pathol. 2010 Feb;23(2):205-12. doi: 10.1038/modpathol.2009.159. Epub 2009 Nov 6. Mod Pathol. 2010. PMID: 19898421 Free article.

10

Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases.

Bhargava R, Beriwal S, Dabbs DJ, Ozbek U, Soran A, Johnson RR, Brufsky AM, Lembersky BC, Ahrendt GM. Bhargava R, et al. Cancer. 2010 Mar 15;116(6):1431-9. doi: 10.1002/cncr.24876. Cancer. 2010. PMID: 20131351 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

957 results

Search Page

Filters